drugset / Trial / NCT00263926

Efficacy and Safety of a Purified Standardised Wasp Venom Preparation

NCT00263926 ↗

Phase 3 Completed Allergopharma GmbH & Co. KG
RandomizedParallel-groupOpen-labelTreatment

Summary

The trial is performed to assess efficacy and safety of a purified standardised wasp venom preparation in wasp venom allergy

Timeline

Start
2001-03
Primary completion
2007-05
Completion
2010-11

Drugs

EvaluationDrugModalityDoseRoute
Subject wasp venom Unknown — —

Indications